Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Conducting Internal Audits in MDI Production

Posted on By

SOP for Conducting Internal Audits in MDI Production

Internal Audit Procedures in MDI Production

1) Purpose

The purpose of this SOP is to establish procedures for conducting internal audits in metered-dose inhaler (MDI) production to assess compliance with quality management systems, identify areas for improvement, and ensure adherence to regulatory requirements.

2) Scope

This SOP applies to all personnel involved in internal audit activities within the MDI production facility, including internal auditors, quality assurance managers, production supervisors, and regulatory affairs personnel.

3) Responsibilities

The responsibilities for this SOP include planning and conducting audits, documenting audit findings, and implementing corrective actions. Specific roles include:
Internal Auditors: Plan and execute internal audits according to audit schedules and procedures.
Quality Assurance Managers: Review audit findings, ensure corrective actions are implemented, and monitor audit effectiveness.
Production Supervisors: Provide access to production areas and assist auditors during audits.
Regulatory Affairs Personnel: Ensure audits comply with regulatory requirements and guidelines.

See also  SOP for Batch Manufacturing Record for MDIs

4) Procedure

4.1 Audit Planning
4.1.1 Develop audit plans based on risk assessment, regulatory requirements, and previous audit findings.
4.1.2 Define audit objectives, scope, and criteria for assessing compliance.
4.2 Audit Execution
4.2.1 Conduct opening meetings with auditees to explain audit objectives and

procedures.
4.2.2 Perform on-site inspections, document reviews, and interviews with personnel.
4.3 Audit Findings
4.3.1 Document audit findings, including non-conformities, observations, and areas of improvement.
4.3.2 Classify audit findings based on severity and impact on compliance and product quality.
4.4 Corrective Actions
4.4.1 Communicate audit findings to relevant departments and initiate corrective actions.
4.4.2 Monitor implementation of corrective actions and verify effectiveness.
4.5 Audit Report and Follow-up
4.5.1 Prepare audit reports summarizing findings, conclusions, and recommendations.
4.5.2 Conduct follow-up audits to verify closure of audit findings and continuous improvement.

See also  SOP for HVAC System Maintenance in MDI Production

5) Abbreviations, if any

MDI: Metered-Dose Inhaler
SOP: Standard Operating Procedure

6) Documents, if any

Audit plans, audit reports, corrective action plans, and audit schedules should be maintained as part of the quality management system.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and ICH for internal audit requirements in pharmaceutical manufacturing.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: SOP for Tap Density Testing in Granules
Next Post: SOP for Ointment Preparation Tank

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version